Author | David A. Bond, MD | OncLive

Author | David A. Bond, MD


Dr. Bond on Second Cancers Following CLL Treatment

August 07, 2019

David A. Bond, MD, assistant professor, The Ohio State University, discusses the high rates of second cancers in both treatment-naïve and pretreated patients with chronic lymphocytic leukemia who received BTK inhibitors.